Combining ARPIs With Radionuclide Therapy Tied to Better Survival in Metastatic CRPC

By News Health
18 hours Ago

(MedPage Today) — A secondary analysis of the phase III VISION trial presented at this year’s American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium found that adding androgen receptor pathway inhibitors (ARPIs) to &#185…

Source link : https://www.medpagetoday.com/meetingcoverage/gucsvideopearls/114748

Author :

Publish date : 2025-03-20 15:31:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Maternal Deaths Remain to Surge Despite Healthcare Advances

GLP-1s and Bariatric Surgery: Before, After, or Both?

Cuts for ID Research Threaten Public Health, Local Economies

3D Total-body Imaging Improves Biopsy ‘Hit’ Rates

Lives at risk due to medical scan mistakes, says ombudsman

Alzheimer's May Be Delayed in Asymptomatic Patients, Small Trial Suggests